about
Advances in the treatment of central serous chorioretinopathyChoroidal imaging: A review.The incidence of central serous chorioretinopathy after photorefractive keratectomy and laser in situ keratomileusis.Central serous chorioretinopathy: update on pathophysiology and treatment.Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.Effects of smoking on visual acuity of central serous chorioretinopathy patients.Choroidal thickness profi le in healthy Indian subjects.QT interval dispersion in the patients with central serous chorioretinopathySystem review and meta-analysis on photodynamic therapy in central serous chorioretinopathy.Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis.Photodynamic therapy: current role in the treatment of chorioretinal conditionsChoroidal thickness profile in healthy Indian children.Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy.Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy.Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs"Optic neuritis" that is neitherEffect of half adult dose of oral Rifampicin (300mg) in patients with idiopathic central serous chorioretinopathyEn face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathyRepeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography.Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy.Central serous chorioretinopathy, corticosteroids, and uveitis.Evaluation of verteporfin pharmakokinetics--redefining the need of photosensitizers in ophthalmology.Central serous chorioretinopathy: a review of epidemiology and pathophysiology.Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.Fundus autofluorescence applications in retinal imaging.Traumatic central serous chorioretinopathy.Multifocal central serous chorioretinopathy associated with steroids in a patient with myasthenia gravisShallow Anterior Chamber in a Severe Case of Unilateral Acute Central Serous Retinal Detachment.Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy.Comment on: Traumatic central serous chorioretinopathy.Choroidal thickness measurements during central serous chorioretinopathy treatment.Chronic Central Serous Chorioretinopathy in a Patient with Pigment Dispersion Syndrome: A Possible Correlation.Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.Gonadal Hormones and Retinal Disorders: A Review.Choroidal Haller's and Sattler's Layers Thickness in Normal Indian Eyes.Development of Central Serous Chorioretinopathy following Chalazion Removal with Intralesional Triamcinolone Injection: A Case Report
P2860
Q28088443-324D8B8F-F804-4F28-A36C-440FE3CEB875Q33620471-8F45E2D2-DB24-4224-8FED-04F9A3B9C2D1Q34240123-69A54188-3E2C-4CC9-AFBE-884EEAF09837Q34587658-1D03578A-2261-4416-9BDC-D999B0C67F1FQ34796150-DA3C9130-593C-48CF-852A-9DA39704727BQ34809984-A5AE9A8F-FAA7-4163-9F25-68CF7A44BE78Q34909559-21302FC5-97F2-499D-9061-0BE77A337FAEQ35075372-AFF05C3D-26B3-4559-BAE1-9F2F1CE2995FQ35209632-478DE3C5-32E1-4F09-99AA-A2E9738187A7Q35567966-3600D8F7-BCF8-4FFE-B090-B6960F28D251Q35826493-A6320C3A-2C13-41EF-980D-A7CA0F8B955FQ35888341-F91716F5-7573-45C8-94DF-3EAE11F7B085Q35999611-63B6A118-114E-4C1E-94C7-46CCB305BA81Q36149820-AB48F327-CC38-47DD-A70A-0E35DBF2A002Q36342993-BCBCDC12-C71A-4AF3-87A6-3AA218A3AE71Q36685428-2A19AFB6-885A-40E3-B391-2C499348D535Q36793195-93AD1F96-92A6-4EEF-A3A5-65AFDBF9F19DQ37040132-2DD4AD50-0E86-4BD7-968D-1A305B2AAB6EQ37405446-69A7225E-4F93-44D3-818B-4A8709A73A68Q37619588-E9729711-A7C8-452E-8D82-FB525D38EE33Q37716564-E39512C2-AABA-4ED5-8FC4-9A766E519A7AQ37729439-1A4521C5-8C81-47D1-9B9D-6D0B988FC967Q37992703-3DBB4CA5-F3DA-447D-932F-92BA1A5DF9FFQ38023892-D2E6E340-49BC-4075-A058-46FC458F3A68Q38025702-FA95C914-47DE-4CCF-BAA1-137C1A24A8A8Q38160720-A5E68FE2-7C43-4E8A-A1DD-649CD3B48B3CQ38542359-96ABF941-EDFC-45FD-90E4-C937701162A4Q41057322-1DAB7292-3562-4677-931F-C5A570D221EAQ42109280-294CD740-8A9C-4A48-AF78-7E9D3C3B21ABQ42195454-1F6A7229-3F33-4F1B-9070-0957E9C65741Q42643950-5AEBA84E-91D6-421B-A0E7-690136DA0031Q43064149-4951614C-3A58-4435-BA84-844250182D7FQ46277762-0931C355-4E5C-4DAC-A133-2B4196364FF8Q47431938-C9313DF1-F18A-4DF1-A8BF-75F0169DA5C0Q54987173-5CD64C44-3DBC-4750-81C5-2C12145A20DFQ54990705-29C647B3-4ADA-4CE7-8730-38758F516432Q55044744-28109EFE-150A-49FF-901F-8D1E711C0E39Q57494018-449980FB-CAE8-4407-BBA2-2C00EFF650CF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review and update of central serous chorioretinopathy.
@en
Review and update of central serous chorioretinopathy.
@nl
type
label
Review and update of central serous chorioretinopathy.
@en
Review and update of central serous chorioretinopathy.
@nl
prefLabel
Review and update of central serous chorioretinopathy.
@en
Review and update of central serous chorioretinopathy.
@nl
P2093
P1476
Review and update of central serous chorioretinopathy.
@en
P2093
Adam H Ross
Alexander Ross
Quresh Mohamed
P304
P356
10.1097/ICU.0B013E3283459826
P577
2011-05-01T00:00:00Z